Lu-177 DOTA-TATE for peptide receptor radionuclide therapy (PRRT): organ-, tumor- and blood kinetics

被引：0
|
作者：
Wehrmann, C. [1 ]
Senftleben, S. [1 ]
Baum, R. P. [1 ]
机构：
[1] Zent Klin Bad Berka, Bad Berka, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2006年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S338 / S339
页数：2
相关论文
共 50 条
  • [21] 177Lu-DOTA-TATE in Peptide Receptor Radionuclide Therapy: first year experience in Turkey
    Kabasakal, L.
    Demirci, E.
    Ocak, M.
    Decristoforo, C.
    Papilla, C.
    Araman, A.
    Uslu, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S428 - S428
  • [22] Repeated cycles of peptide receptor radionuclide therapy (PRRT) - Results and side-effects of the radioisotope 90Y-DOTA TATE, 177Lu-DOTA TATE or 90Y/177Lu-DOTA TATE therapy in patients with disseminated NET
    Pach, Dorota
    Sowa-Staszczak, Anna
    Kunikowska, Jolanta
    Krolicki, Leszek
    Trofimiuk, Malgorzata
    Stefanska, Agnieszka
    Tomaszuk, Monika
    Glowa, Boguslaw
    Mikolajczak, Renata
    Pawlak, Dariusz
    Jabrocka-Hybel, Agata
    Hubalewska-Dydejczyk, Alicja B.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2012, 102 (01) : 45 - 50
  • [23] Morphologic and metabolic response assessment of 177Lu-DOTA-TATE peptide receptor radionuclide therapy (PRRT) with 68Ga-DOTA-TOC PET/CT
    Gaertner, F. C.
    Hillerer, C.
    Lapa, C.
    Miederer, M.
    D'Alessandria, C.
    Wester, H.
    Schwaiger, M.
    Scheidhauer, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S267 - S267
  • [24] Peptide receptor radionuclide therapy (PRRT) with [177Lu]Lu-DOTA-TATE in the treatment of malignant insulinoma: a case report of remarkable clinical and imaging response
    Barbosa, D.
    Duarte, H.
    Paula Santos, A.
    Ferro, J.
    Prospero, I.
    Silva, D.
    Gil-Santos, S.
    Calheiros, R.
    Fontao de Castro, S.
    Ferreira, G.
    Teixeira, P.
    Lucena Sampaio, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S219 - S219
  • [25] Concomitant Dosimetry During Radionuclide Peptide Therapy with 177-Lu-DOTA-tate and 177-Lu-Lanreotide
    Heute, D. R.
    Dobrozemsky, G.
    Traub, T.
    Warwitz, B.
    von Guggenberg, E.
    Gabriel, M.
    Virgolini, I.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 : S202 - S202
  • [26] Peptide receptor radionuclide therapy using somatostatin receptor antagonists: first results of biodistribution and dosimetry of Lu-177 DOTA-LM3 compared to Lu-177 DOTATOC
    Schuchardt, Christiane
    Kulkarni, Harshad
    Singh, Aviral
    Mueller, Dirk
    Fani, Melpomeni
    Maecke, Helmut
    Baum, Richard
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2019, 60
  • [27] Peptide receptor radionuclide therapy (PRRT) in radioiodine-refractory thyroid cancer: A case report of significant response to lu177 DOTA-TATE treatment (vol 66, pg 269, 2022)
    Mottaghi, Mahdi
    [J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (04): : 587 - 587
  • [28] Serial Dosimetry in Peptide Receptor Radionuclide Therapy using Lu-177 DOTATATE or Lu-177 DOTATOC in the same Patient
    Schuchardt, C.
    Kulkarni, H.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S139 - S139
  • [29] Treatment with tandem [90Y]DOTA-TATE and [177Lu]DOTA-TATE of neuroendocrine tumours refractory to conventional therapy
    E. Seregni
    M. Maccauro
    C. Chiesa
    L. Mariani
    C. Pascali
    V. Mazzaferro
    F. De Braud
    R. Buzzoni
    M. Milione
    A. Lorenzoni
    A. Bogni
    A. Coliva
    S. Lo Vullo
    E. Bombardieri
    [J]. European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 223 - 230
  • [30] Comparison of Lu-177 DOTA-TATE sequential planar dosimetry scans with Ga-68 DOTA-TATE PET/CT images in patients with neuroendocrine tumours
    Sainz Esteban, A.
    Prasad, V.
    Carril Carril, J. M.
    Baum, R. P.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S231 - S232
12345